374
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Investigation of phase diagrams and physical stability of drug–polymer solid dispersions

, , , , , , & show all
Pages 105-117 | Received 01 May 2014, Accepted 14 Jul 2014, Published online: 12 Aug 2014

References

  • Kerns EH. High throughput physicochemical profiling for drug discovery. J Pharm Sci 2001;90:1838–1858
  • Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420
  • Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29:278–287
  • Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol 2006;6:501–508
  • Potta SG, Minemi S, Nukala RK, et al. Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. J Biomed Nanotechnol 2010;6:634–640
  • Sohma Y, Hayashi Y, Ito T, et al. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage. J Med Chem 2003;46:4124–4135
  • Patel JR, Carlton RA, Yuniatine F, et al. Preparation and structural characterization of amorphous spray-dried dispersions of tenoxicam with enhanced dissolution. J Pharm Sci 2012;101:641–663
  • Miller DA, McConville JT, Yang W, et al. Hot-melt extrusion for enhanced delivery of drug particles. J Pharm Sci 2007;96:361–376
  • Maniruzzaman M, Rana MM, Boateng JS, et al. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers. Drug Dev Ind Pharm 2013;39:218–227
  • Sinha S, Ali M, Baboota S, et al. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech 2010;11:518–527
  • Betageri GV, Makarla KR. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int J Pharm 1995;126:155–160
  • Rawat S, Jain SK. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes. Eur J Pharm Biopharm 2004;57:263–267
  • Hamada H, Ishihara K, Masuoka N, et al. Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins. J Biosci Bioeng 2006;102:369–371
  • Shikhar A, Bommana MM, Gupta SS, Squillante E. Formulation development of carbamazepine-nicotinamide co-crystals complexed with gamma-cyclodextrin using supercritical fluid process. J Supercritical Fluids 2011;55:1070–1978
  • Chang JS, Radosevich M, Jin Y, Cha DK. Enhancement of phenanthrene solubilization and biodegradation by trehalose lipid biosurfactants. Environ Toxicol Chem 2004;23:2816–2822
  • Stephenson GA, Aburub A, Woods TA. Physical stability of salts of weak bases in the solid-state. J Pharm Sci 2011;100:1607–1617
  • Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281–1302
  • Janssens S, Van den Mooter G. Review: physical chemistry of solid dispersions. J Pharm Pharmacol 2009;61:1571–1586
  • Srinarong P, de Waard H, Frijlink HW, Hinrichs WL. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations. Expert Opin Drug Deliv 2011;8:1121–1140
  • Bikiaris DN. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opin Drug Deliv 2011;8:1501–1519
  • Karavas E, Ktistis G, Xenakis A, Georgarakis E. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions. Drug Dev Ind Pharm 2005;31:473–489
  • Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 2006;95:2692–2705
  • Qian F, Huang J, Hussain MA. Drug-polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development. J Pharm Sci 2010;99:2941–2947
  • Hancock BC, Shamblin SL, Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res 1995;12:799–806
  • Ahlneck C, Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int J Pharm 1990;62:87–95
  • Flory PJ, ed. Principle of polymer chemistry. Ithaca: Cornell University Press; 1953
  • Rubinstein M, Marsac PJ, eds. Polymer physics. New York: Oxford University Press; 2003
  • Marsac PJ, Shamblin SL, Taylor LS. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 2006;23:2417–2426
  • Marsac PJ, Li T, Taylor LS. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm Res 2009;26:139–151
  • Zhao Y, Inbar P, Chokshi HP, et al. Prediction of the thermal phase diagram of amorphous solid dispersions by Flory-Huggins theory. J Pharm Sci 2011;100:3196–3207
  • Pajula K, Taskinen M, Lehto VP, et al. Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram. Mol Pharm 2010;7:795–804
  • Sun Y, Tao J, Zhang GG, Yu L. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc. J Pharm Sci 2010;99:4023–4031
  • Hildebrand JH, Scott RL, eds. The solubility of nonelectrolytes. 3rd ed. New York: Reinhold Pub. Corp; 1950
  • Lin D, Huang Y. A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions. Int J Pharm 2010;399:109–115
  • Nishi T, Wang TT. Melting point depression and kinetic effects of cooling on crystallization in poly(vinylidene fluoride)-poly(methyl methacrylate) mixtures. Macromolecules 1975;8:909–915
  • Rim PB, Runt JP. Melting point depression in crystalline/compatible polymer blends. Macromolecules 1984;17:1520–1526
  • Cortazar MM, Calahorra ME, Guzmán GM. Melting point depression in poly (ethylene oxide)-poly (methyl methacrylate) blends. Eur Polym J 1982;18:165–166
  • Liberman SA, De S. Gomes A, Macchi EM. Compatibility in poly(ethylene oxide)–poly(methyl methacrylate) blends. J Polym Sci 1984;22:2809–2815
  • Van Krevelen DW, Te Nijenhuis K, eds. Properties of polymers. 4th ed. Amsterdam, Boston: Elsevier B.V.; 2009
  • Gramaglia D, Conway BR, Kett VL, et al. High speed DSC (hyper-DSC) as a tool to measure the solubility of a drug within a solid or semi-solid matrix. Int J Pharm 2005;301:1–5
  • Greenhalgh DJ, Williams AC, Timmins P, York P. Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci 1999;88:1182–1190
  • Hot Melt Extrusion with BASF Pharma Polymers Compendium; 2012
  • Mididoddi PK, Repka MA. Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm 2007;66:95–105
  • Barton AFM, ed. Handbook of solubility parameters and other cohesion parameters. 2nd ed. Boca Raton, London, New York, Washington DC: CRC Press, LLC.; 1991
  • Hansen CM, ed. Hansen solubility parameters a user’s handbook. Boca Raton (FL): CRC Press, LLC.; 2000
  • Hiemenz PC, Lodge TP, eds. Polymer chemistry. 2nd ed. Marcel Dekker, Inc.: New York, Basel; 2007
  • Qiu Z, Ikehara T, Nishi T. Miscibility and crystallization in crystalline/crystalline blends of poly(butylene succinate)/poly(ethylene oxide). Polymer 2003;44:2799–2806
  • Cheng SZD, ed. Phase transitions in polymers: the role of metastable states. 1st ed. Amsterdam: Elsevier Science; 2008
  • Iskandar M, Krause S. Phase separation instyrene-a-methyl styrene block copolymers. Polym Alloys Polym Sci Technol 1978;10:231–243
  • Newman A, Munson E. Characterizing miscibility in amorphous solid dispersions. Am Pharm Rev 2012;2012
  • Ivanisevic I, Bates S, Chen P. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions. J Pharm Sci 2009;98:3373–3386
  • Rumondor AC, Ivanisevic I, Bates S, et al. Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm Res 2009;26:2523–2534
  • Nollenberger K, Gryczke A, Meier C, et al. Pair distribution function X-ray analysis explains dissolution characteristics of felodipine melt extrusion products. J Pharm Sci 2009;98:1476–1486
  • Newman A, Engers D, Bates S, et al. Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction. J Pharm Sci 2008;97:4840–4856
  • Pham TN, Watson SA, Edwards AJ, et al. Analysis of amorphous solid dispersions using 2D solid-state NMR and 1H T1 relaxation measurements. Mol Pharm 2010;7:1667–1691
  • Vogt FG, Williams GR. Analysis of a nanocrystalline polymer dispersion of ebselen using solid-state NMR, Raman microscopy, and powder X-ray diffraction. Pharm Res 2012;29:1866–1881
  • Ito A, Watanabe T, Yada S, et al. Prediction of recrystallization behavior of troglitazone/polyvinylpyrrolidone solid dispersion by solid-state NMR. Int J Pharm 2010;383:18–23
  • Brettmann BK, Myerson AS, Trout BL. Solid-state nuclear magnetic resonance study of the physical stability of electrospun drug and polymer solid solutions. J Pharm Sci 2012;101:2185–2193
  • Schachter DM, Xiong J, Tirol GC. Solid state NMR perspective of drug-polymer solid solutions: a model system based on poly(ethylene oxide). Int J Pharm 2004;281:89–101
  • Yang M, Wang P, Suwardie H, Gogos C. Determination of acetaminophen's solubility in poly(ethylene oxide) by rheological, thermal and microscopic methods. Int J Pharm 2011;403:83–89
  • Brostow W, Chiu R, Kalogeras IM, Vassilikou-Dova A. Prediction of glass transition temperatures: binary blends and copolymers. Mater Lett 2008;62:3152–3155
  • Seyler RJ, ed. Assignment of the glass transition. Philadelphia: American Society for Testing and Materials; 1994
  • Menard KP, ed. Dynamic mechanical analysis: an introduction, technique and applications. Boca Raton (FL): CRC Press, LLC.; 1999
  • Koike T. Determination of glass transition temperature from dielectric analysis for a series of epoxide oligomers. J Appl Polym Sci 1992;45:901–907
  • Fox TG. Influence of diluent and of copolymer composition on the glass temperature of a polymer system. Bull Am Phys Soc 1956;1:123–135
  • Gordon M, Taylor JS. Ideal copolymers and the second-order transitions of synthetic rubbers. I. non-crystalline copolymers. J Appl Chem 1952;2:493–500
  • Kwei TK. The effect of hydrogen bonding on the glass transition temperatures of polymer mixtures. J Polym Sci 1984;22:307–313
  • Couchman PR, Karasz FE. A classical thermodynamic discussion of the effect of composition on glass transition temperatures. Macromolecules 1978;11:117–119
  • Qian F, Huang J, Zhu Q, et al. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion? Int J Pharm 2010;395:232–235
  • Pinal R. Entropy of mixing and the glass transition of amorphous mixtures. Entropy 2008;10:207–233
  • Baird JA, Taylor LS. Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev 2012;64:396–421
  • Marsac PJ, Rumondor AC, Nivens DE, et al. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone). J Pharm Sci 2010;99:169–185
  • Qi S, Belton P, Nollenberger K, et al. Compositional analysis of low quantities of phase separation in hot-melt-extruded solid dispersions: a combined atomic force microscopy, photothermal fourier-transform infrared microspectroscopy, and localised thermal analysis approach. Pharm Res 2011;28:2311–2326
  • Urbanetz NA. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur J Pharm Sci 2006;28:67–76
  • Qian F, Wang J, Hartley R, et al. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications. Pharm Res 2012;29:2765–2776
  • Beak IH, Kim MS. Improved supersaturation and oral absorption of dutasteride by amorphous solid dispersions. Chem Pharm Bull (Tokyo) 2012;60:1468–1473
  • Hirasawa N, Ishise S, Miyata H, Danjo K. An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems. Drug Dev Ind Pharm 2003;29:997–1004
  • Korhonen O, Bhugra C, Pikal MJ. Correlation between molecular mobility and crystal growth of amorphous phenobarbital and phenobarbital with polyvinylpyrrolidone and L-proline. J Pharm Sci 2008;97:3830–3841
  • Andronis V, Zografi G. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J Non-Crystalline Solids 2000;271:236–248
  • Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci 2009;98:2549–2572
  • van der Lee R, Pfaffendorf M, Koopmans RP, et al. Comparison of the time courses and potencies of the vasodilator effects of nifedipine and felodipine in the human forearm. Blood Press 2001;10:217–222
  • Mannisto PT, Mantyla R, Nykanen S, et al. Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother 1982;21:730–733

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.